Turnover: 700000 EUR (2019)

Country: France

We are an innovative clinical-stage gene therapy company dedicated to the discovery, development and commercialization of innovative therapies for patients with severe neurodegenerative diseases of the retina.

Studies mentioning this company

The gene therapy market - France

Other companies mentioned:

  • Sanofi Aventis
  • Cellectis
  • Généthon
  • Gensight Biologics

> Besoin de plus d'information sur cette entreprise (SWOT, PESTEL, son marché) ? Demandez à SectorGPT (gratuit)

 

Ask Sector-GPT  

Sector-GPT est la première IA dédiée aux informations sectorielles.